Bluejay Diagnostics Stock Total Debt
| BJDX Stock | USD 1.50 0.04 2.60% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Bluejay Diagnostics' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Bluejay Diagnostics Company Total Debt Analysis
Bluejay Diagnostics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bluejay Diagnostics Total Debt | 222.25 K |
Most of Bluejay Diagnostics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bluejay Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Bluejay Diagnostics has a Total Debt of 222.25 K. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and 99.99% lower than that of the Health Care industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Bluejay Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bluejay Diagnostics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bluejay Diagnostics could also be used in its relative valuation, which is a method of valuing Bluejay Diagnostics by comparing valuation metrics of similar companies.Bluejay Diagnostics is currently under evaluation in total debt category among its peers.
Bluejay Fundamentals
| Return On Equity | -2.01 | ||||
| Return On Asset | -0.8 | ||||
| Current Valuation | (687.46 K) | ||||
| Shares Outstanding | 1.49 M | ||||
| Shares Owned By Insiders | 0.25 % | ||||
| Shares Owned By Institutions | 2.48 % | ||||
| Number Of Shares Shorted | 35.65 K | ||||
| Price To Book | 0.58 X | ||||
| Price To Sales | 54.99 X | ||||
| Gross Profit | 48.91 K | ||||
| EBITDA | (6.7 M) | ||||
| Net Income | (7.72 M) | ||||
| Cash And Equivalents | 15.34 M | ||||
| Cash Per Share | 0.76 X | ||||
| Total Debt | 222.25 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 17.41 X | ||||
| Book Value Per Share | 6.98 X | ||||
| Cash Flow From Operations | (7.82 M) | ||||
| Short Ratio | 0.71 X | ||||
| Earnings Per Share | 277.20 X | ||||
| Target Price | 256.0 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 2.24 M | ||||
| Total Asset | 6.66 M | ||||
| Retained Earnings | (34.67 M) | ||||
| Working Capital | 4.09 M | ||||
| Net Asset | 6.66 M |
About Bluejay Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bluejay Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bluejay Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bluejay Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.